Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


June 03, 2015 6:50 AM ET

Health Care Technology

Company Overview of Molecular Health AG

Company Overview

Molecular Health AG, a biomedical company, offers a computational system that transforms molecular data into clinically actionable information to provide various cancer treatment options for cancer patients. The company offers TreatmentMAP, a treatment decision support solution that guides physicians and patients in the use of genetic, clinical, molecular, and efficacy data. Its solutions include TreatmentMAP-targeted panel, a test that includes various genetic variants that develop a treatment plan for newly diagnosed solid tumor cancer; and TreatmentMAP-whole exome, which analyzes various genes to identify generic variation against a patient’s normal gene set in the areas of difficult to t...

Dufourstrasse 25

Basel,  4010

Switzerland

Founded in 2004

Phone:

41 61 271 60 34

Fax:

41 61 273 23 70

Key Executives for Molecular Health AG

Chief Executive Officer
Founder and Chairman
Age: 52
Co-Founder
President of Molecular Health Inc - USA
Chief Innovation Officer
Compensation as of Fiscal Year 2014.

Molecular Health AG Key Developments

Molecular Health Appoints Rudi Schmidt as Executive Vice President of Corporate Communications & Public Affairs

Molecular Health announced that on 1 January 2015 Rudi Schmidt accepted the position of Executive Vice President of Corporate Communications & Public Affairs at the company. Schmidt comes from the Asklepios clinic group, where he was head of Communications and Marketing for nine years.

MolecularHealth Provides Unprecedented Reimbursement Support with RxAssistance

MolecularHealth announced an important new component of its TreatmentMAP(TM) offering in the United States, called MolecularHealth(TM) RxAssistance. This new service is a value-added benefit for patients and their doctors, providing a level of reimbursement support not previously seen in the molecular diagnostic industry. Unlike reimbursement services offered by other companies that only assess insurance options for the molecular diagnostic test itself, RxAssistance evaluates insurance options for the therapies recommended by its tests. RxAssistance is designed to help streamline the reimbursement process and provide physicians and patients with support and education about payer reimbursement for treatment options. Each patient's TreatmentMAP results report and insurance information is reviewed by MolecularHealth's reimbursement specialist, a Certified Professional Coder(R), prior to results being sent to the physician. Off-label or investigational products recommended for treatment are flagged and information is gathered, including the likelihood a payer will reimburse for the suggested treatments and any additional information that will be needed to receive reimbursement, such as a letter of medical necessity. RxAssistance has been integrated into TreatmentMAP's end-to-end offering and is currently included as a value-added component of all orders. When a physician receives a patient's results report, they also receive an accompanying RxAssistance report, providing information on pre-authorization, patient responsibility for co-pays and deductibles, letters of medical necessity, and step therapy requirements and/or medical benefit formularies.

Molecularhealth Adds Fadi Braiteh to its Advisory Board

MolecularHealth announced the addition of Fadi Braiteh, M.D., to its advisory board. Dr. Braiteh is a practicing oncologist with the Comprehensive Cancer Centers of Nevada, and a leading specialist on gastro-intestinal, digestive system and breast cancer oncology. He joins a board comprised of numerous nationally and internationally-recognized oncology and pathology experts.

Similar Private Companies By Industry

Company Name Region
Exsigno Stäfa Gruppe Europe
EBD GmbH Europe
Molecular Health AG Europe
Ascendys Sarl Europe
Swisscom Health AG Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Molecular Health AG, please visit www.molecularhealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.